Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Morlock

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
The Journal of Rheumatology|April 3, 2016
Patients with Gout Treated with Conventional Urate-lowering Therapy: Association with Disease Control, Health-related Quality of Life, and Work ProductivityRobert Wood, Steve Fermer, Sulabha Ramachandran, et al.
Journal of Psychiatric Research|May 9, 2009
Development of a patient-reported assessment to identify placebo responders in a generalized anxiety disorder trialDouglas Feltner, Cheryl Hill, William Lenderking, et al.
Frontiers in Psychiatry|April 11, 2022
Corrigendum: Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health OutcomesRichard Matzopoulos, Robert Morlock, Amy Morlock, et al.
Postgraduate Medicine|November 19, 2015
A world of hurt: failure to achieve treatment goals in patients with gout requires a paradigm shiftPuja Khanna, Dinesh Khanna, Chris Storgard, et al.
Frontiers in Psychiatry|January 20, 2022
Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health OutcomesRichard Matzopoulos, Robert Morlock, Amy Morlock, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|May 25, 2007
Physician observations and perceptions of positive and negative symptoms of schizophrenia: a multinational, cross-sectional surveyYves Lecrubier, Richard Perry, Gary Milligan, et al.
Advances in Therapy|June 22, 2022
US Population Reference Values for Health-Related Quality of Life Questionnaires Based on Demographics of Patients with Prostate CancerDavid Cella, Arijit Ganguli, James Turnbull, et al.
Journal of Managed Care & Specialty Pharmacy|November 25, 2022
COVID-19 vaccination and race - A nationwide survey of vaccination status, intentions, and trust in the US general populationCarolyn Brown, Amy Morlock, Karin Blakolmer, et al.
Psychiatry (Edgmont (Pa. : Township))|September 1, 2010
The 4-Item Negative Symptom Assessment (NSA-4) Instrument: A Simple Tool for Evaluating Negative Symptoms in Schizophrenia Following Brief TrainingLarry Alphs, Robert Morlock, Cheryl Coon, et al.
Frontiers in Psychiatry|March 20, 2025
Characteristics and mental health of psychedelic mushroom and multi-psychedelic users relative to non-psychedelic users in American adults, 2020-2021Sofia Abramsky-Sze, Elliot Marseille, Richard Matzopoulos, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
The Journal of Rheumatology|April 3, 2016
Patients with Gout Treated with Conventional Urate-lowering Therapy: Association with Disease Control, Health-related Quality of Life, and Work ProductivityRobert Wood, Steve Fermer, Sulabha Ramachandran, et al.
Journal of Psychiatric Research|May 9, 2009
Development of a patient-reported assessment to identify placebo responders in a generalized anxiety disorder trialDouglas Feltner, Cheryl Hill, William Lenderking, et al.
Frontiers in Psychiatry|April 11, 2022
Corrigendum: Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health OutcomesRichard Matzopoulos, Robert Morlock, Amy Morlock, et al.
Postgraduate Medicine|November 19, 2015
A world of hurt: failure to achieve treatment goals in patients with gout requires a paradigm shiftPuja Khanna, Dinesh Khanna, Chris Storgard, et al.
Frontiers in Psychiatry|January 20, 2022
Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health OutcomesRichard Matzopoulos, Robert Morlock, Amy Morlock, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|May 25, 2007
Physician observations and perceptions of positive and negative symptoms of schizophrenia: a multinational, cross-sectional surveyYves Lecrubier, Richard Perry, Gary Milligan, et al.
Advances in Therapy|June 22, 2022
US Population Reference Values for Health-Related Quality of Life Questionnaires Based on Demographics of Patients with Prostate CancerDavid Cella, Arijit Ganguli, James Turnbull, et al.
Journal of Managed Care & Specialty Pharmacy|November 25, 2022
COVID-19 vaccination and race - A nationwide survey of vaccination status, intentions, and trust in the US general populationCarolyn Brown, Amy Morlock, Karin Blakolmer, et al.
Psychiatry (Edgmont (Pa. : Township))|September 1, 2010
The 4-Item Negative Symptom Assessment (NSA-4) Instrument: A Simple Tool for Evaluating Negative Symptoms in Schizophrenia Following Brief TrainingLarry Alphs, Robert Morlock, Cheryl Coon, et al.
Frontiers in Psychiatry|March 20, 2025
Characteristics and mental health of psychedelic mushroom and multi-psychedelic users relative to non-psychedelic users in American adults, 2020-2021Sofia Abramsky-Sze, Elliot Marseille, Richard Matzopoulos, et al.
Pageof 5